{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:21:18Z","timestamp":1780366878274,"version":"3.54.1"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.thromres.2020.08.039","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T11:18:09Z","timestamp":1598527089000},"page":"143-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-8861","authenticated-orcid":false,"given":"Serena","family":"Del Turco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Vianello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosetta","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0809-4374","authenticated-orcid":false,"given":"Giuseppina","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.08.039_bb0005","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"issue":"e8","key":"10.1016\/j.thromres.2020.08.039_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2020.08.039_bb0020","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2020.08.039_bb0025","series-title":"Coronavirus Disease (COVID-19). Situation Report \u2013 176. July 14 2020","author":"WHO","year":"2020"},{"key":"10.1016\/j.thromres.2020.08.039_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fmed.2020.00321","article-title":"Spread and impact of COVID-19 in China: a systematic review and synthesis of predictions from transmission-dynamic models","volume":"7","author":"Lin","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.thromres.2020.08.039_bb0035","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fcell.2020.00410","article-title":"New insights of emerging SARS-CoV-2: epidemiology, etiology, clinical features, clinical treatment, and prevention","volume":"8","author":"Guo","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1473-3099(20)30243-7","article-title":"Estimates of the severity of coronavirus disease 2019: a model-based analysis","volume":"20","author":"Verity","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.thromres.2020.08.039_bb0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jmv.25689","article-title":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China","volume":"92","author":"Wang","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0050","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0060","article-title":"The science underlying COVID-19: implications for the cardiovascular system","author":"Liu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.08.039_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009683","article-title":"Inpatient and outpatient infection as a trigger of cardiovascular disease: the ARIC study","volume":"7","author":"Cowan","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2020.08.039_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/pgmj.2005.037515","article-title":"Cardiovascular complications of severe acute respiratory syndrome","volume":"82","author":"Yu","year":"2006","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.thromres.2020.08.039_bb0075","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/eurheartj\/ehm035","article-title":"Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8\u00a0years of autopsies in 34,892 subjects","volume":"28","author":"Madjid","year":"2007","journal-title":"Eur. Heart J."},{"issue":"Suppl. 7","key":"10.1016\/j.thromres.2020.08.039_bb0080","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1086\/432001","article-title":"Underlying disorders and their impact on the host response to infection","volume":"41","author":"Dhainaut","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.thromres.2020.08.039_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104371","article-title":"Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"127","author":"Hu","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","author":"Su","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2020.08.039_bb0095","series-title":"Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis. medRxiv","author":"Shamshirian","year":"2020"},{"key":"10.1016\/j.thromres.2020.08.039_bb0100","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.thromres.2020.08.039_bb0105","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.thromres.2020.08.039_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2020.08.039_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/ajcp\/aqaa062","article-title":"COVID-19 Autopsies, Oklahoma, USA","author":"Barton","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0125","series-title":"Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans","author":"Fox","year":"2020"},{"key":"10.1016\/j.thromres.2020.08.039_bb0130","first-page":"E009","article-title":"A pathological report of three COVID-19 cases by minimally invasive autopsies","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.thromres.2020.08.039_bb0135","first-page":"217","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps","author":"Barnes","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102833","article-title":"Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients","volume":"57","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.thromres.2020.08.039_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1828","article-title":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock","author":"Tavazzi","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.thromres.2020.08.039_bb0150","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2020.08.039_bb0155","article-title":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.thromres.2020.08.039_bb0160","article-title":"The presence of SARS-CoV-2 RNA in feces of COVID-19 patients","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0165","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000000774","article-title":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients","author":"Ling","year":"2020","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.thromres.2020.08.039_bb0170","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.3786","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2020.08.039_bb0175","doi-asserted-by":"crossref","DOI":"10.7326\/M20-2566","article-title":"Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series","author":"Lax","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0185","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.thromres.2020.08.039_bb0190","doi-asserted-by":"crossref","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","author":"Zou","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0195","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa311","article-title":"Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts","author":"Nicin","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2020.08.039_bb0200","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13054-017-1882-z","article-title":"Recombinant human ACE2: acing out angiotensin II in ARDS therapy","volume":"21","author":"Zhang","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2020.08.039_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","author":"Guzik","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00041552-200503000-00011","article-title":"The renin-angiotensin system: peptides and enzymes beyond angiotensin II","volume":"14","author":"Reudelhuber","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.thromres.2020.08.039_bb0215","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tem.2004.03.001","article-title":"ACE2, a new regulator of the renin-angiotensin system","volume":"15","author":"Burrell","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2020.08.039_bb0220","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/BF02877776","article-title":"Reducing cardiovascular risk by blockade of the renin-angiotensin-aldosterone system","volume":"24","author":"Cohn","year":"2007","journal-title":"Adv. Ther."},{"key":"10.1016\/j.thromres.2020.08.039_bb0225","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2011.12.010","article-title":"Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor","volume":"351","author":"Sukumaran","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0230","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.thromres.2020.08.039_bb0235","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/hr.2014.49","article-title":"Role of angiotensin-converting enzyme 2\/angiotensin-(1-7)\/Mas axis in the hypotensive effect of azilsartan","volume":"37","author":"Iwanami","year":"2014","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0240","doi-asserted-by":"crossref","DOI":"10.1111\/jocs.14582","article-title":"ACE inhibitors and COVID-19: we don\u2019t know yet","author":"Khashkhusha","year":"2020","journal-title":"J. Card. Surg."},{"key":"10.1016\/j.thromres.2020.08.039_bb0245","article-title":"Controversy regarding ACE inhibitors\/ARBs in Covid-19","author":"Soria Arcos","year":"2020","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.1863","article-title":"Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence","author":"Sriram","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2020.08.039_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30224-1","article-title":"SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors","volume":"8","author":"Milne","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0260","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0265","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2020.08.039_bb0270","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.thromres.2020.08.039_bb0275","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0280","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0285","series-title":"The Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Death and Severity of Disease in Patients With Coronavirus Disease 2019 (COVID-19): A Meta-analysis","author":"Ghosal","year":"2020"},{"key":"10.1016\/j.thromres.2020.08.039_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.117.309813","article-title":"Endothelial functions","volume":"37","author":"Godo","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0295","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7150\/ijbs.7502","article-title":"The vascular endothelium and human diseases","volume":"9","author":"Rajendran","year":"2013","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.thromres.2020.08.039_bb0300","article-title":"Characteristic electrocardiographic manifestations in patients with COVID-19","author":"He","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0305","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0310","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00424-017-1935-9","article-title":"Hypoxia and aerobic metabolism adaptations of human endothelial cells","volume":"469","author":"Koziel","year":"2017","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.thromres.2020.08.039_bb0315","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.thromres.2020.08.039_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150255","article-title":"Genetic deletion of ACE2 induces vascular dysfunction in C57BL\/6 mice: role of nitric oxide imbalance and oxidative stress","volume":"11","author":"Rabelo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2020.08.039_bb0325","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1253\/circj.CJ-17-1399","article-title":"Type 2 myocardial infarction - an evolving entity","volume":"82","author":"McCarthy","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.thromres.2020.08.039_bb0330","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","author":"Li","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","author":"Siddiqi","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.thromres.2020.08.039_bb0340","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2020.08.039_bb0345","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2020.08.039_bb0350","first-page":"34","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.thromres.2020.08.039_bb0355","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2020.08.039_bb0360","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0365","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.HYP.37.1.72","article-title":"Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells","volume":"37","author":"Heitsch","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.thromres.2020.08.039_bb0370","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijid.2004.04.012","article-title":"Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound","volume":"8","author":"Keyaerts","year":"2004","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.thromres.2020.08.039_bb0375","doi-asserted-by":"crossref","first-page":"104811","DOI":"10.1016\/j.antiviral.2020.104811","article-title":"Antiviral activities of type I interferons to SARS-CoV-2 infection","volume":"179","author":"Mantlo","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0380","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.thromres.2020.08.039_bb0385","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138999","article-title":"Neutrophil extracellular traps in COVID-19","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.thromres.2020.08.039_bb0390","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/ATVBAHA.114.304114","article-title":"Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms","volume":"34","author":"Gould","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0395","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1538-7836.2007.02865.x","article-title":"Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis","volume":"6","author":"Ma","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.039_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2020.08.039_bb0405","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1164\/rccm.201604-0712OC","article-title":"Antihistone properties of C1 esterase inhibitor protect against lung injury","volume":"196","author":"Wygrecka","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0410","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunologic features in severe and moderate coronavirus disease 2019","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2020.08.039_bb0415","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.thromres.2020.08.039_bb0420","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-020-0498-4","article-title":"SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion","author":"Wang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0425","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa231","article-title":"Coronaviruses and the cardiovascular system: acute and long-term implications","author":"Xiong","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2020.08.039_bb0430","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0435","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.thromres.2020.08.039_bb0440","series-title":"Highly Pathogenic Coronavirus N Protein Aggravates Lung Injury by MASP-2-mediated Complement Over-activation","author":"Gao","year":"2020"},{"key":"10.1016\/j.thromres.2020.08.039_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0450","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI126976","article-title":"The HMGB1\/RAGE axis triggers neutrophil-mediated injury amplification following necrosis","volume":"130","author":"Huebener","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2020.08.039_bb0455","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/lt.24129","article-title":"Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure","volume":"21","author":"Basta","year":"2015","journal-title":"Liver Transpl."},{"key":"10.1016\/j.thromres.2020.08.039_bb0460","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1465-9921-12-37","article-title":"Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study","volume":"12","author":"Miniati","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0465","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12931-014-0133-y","article-title":"Conditionally induced RAGE expression by proximal airway epithelial cells in transgenic mice causes lung inflammation","volume":"15","author":"Bodine","year":"2014","journal-title":"Respir. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0470","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s10020-020-00172-4","article-title":"Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?","volume":"26","author":"Andersson","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2020.04.052","article-title":"Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic","author":"Harahsheh","year":"2020","journal-title":"J. Pediatr."},{"key":"10.1016\/j.thromres.2020.08.039_bb0480","doi-asserted-by":"crossref","DOI":"10.1542\/hpeds.2020-0123","article-title":"COVID-19 and Kawasaki disease: novel virus and novel case","author":"Jones","year":"2020","journal-title":"Hosp. Pediatr."},{"key":"10.1016\/j.thromres.2020.08.039_bb0485","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/eji.201747226","article-title":"An immune-molecular hypothesis supporting infectious aetiopathogenesis of Kawasaki disease in children","volume":"48","author":"Capittini","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0490","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2020.08.039_bb0495","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence","author":"Poissy","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.08.039_bb0500","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.039_bb0505","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1160\/TH06-07-0402","article-title":"Parallel decrease of tissue factor surface exposure and increase of tissue factor microparticle release by the n-3 fatty acid docosahexaenoate in endothelial cells","volume":"98","author":"Del Turco","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.039_bb0510","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2019.02569","article-title":"Understanding infection-induced thrombosis: lessons learned from animal models","volume":"10","author":"Beristain-Covarrubias","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0515","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2017","journal-title":"Thromb. Res."},{"issue":"19","key":"10.1016\/j.thromres.2020.08.039_bb0520","article-title":"Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study","volume":"9","author":"Schmitt","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.thromres.2020.08.039_bb0525","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/cvr\/cvt343","article-title":"Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants","volume":"101","author":"Spronk","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0530","first-page":"2550","article-title":"Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury","volume":"119","author":"Scotton","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2020.08.039_bb0535","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbrc.2007.05.092","article-title":"Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity","volume":"359","author":"Du","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.thromres.2020.08.039_bb0540","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","article-title":"Severe COVID-19 infection associated with endothelial activation","volume":"190","author":"Escher","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0545","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.thromres.2020.08.039_bb0550","doi-asserted-by":"crossref","first-page":"5620314","DOI":"10.1155\/2017\/5620314","article-title":"The role of von Willebrand factor in vascular inflammation: from pathogenesis to targeted therapy","volume":"2017","author":"Gragnano","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.thromres.2020.08.039_bb0555","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/jth.13953","article-title":"The role of ADAMTS-13 in the coagulopathy of sepsis","volume":"16","author":"Levi","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.039_bb0560","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.thromres.2020.08.039_bb0565","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00277-020-04019-0","article-title":"Mechanism of thrombocytopenia in COVID-19 patients","volume":"99","author":"Xu","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2020.08.039_bb0570","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2020.06.008","article-title":"Mechanisms involved in the development of thrombocytopenia in patients with COVID-19","volume":"193","author":"Zhang","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0580","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2019.07.013","article-title":"The stimulation of thrombosis by hypoxia","volume":"181","author":"Gupta","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.08.039_bb0585","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.HYP.0000153321.13792.b9","article-title":"Angiotensin II and the endothelium: diverse signals and effects","volume":"45","author":"Watanabe","year":"2005","journal-title":"Hypertension"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820304886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820304886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:43:49Z","timestamp":1758735829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820304886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":117,"alternative-id":["S0049384820304886"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.08.039","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}